RxDoctor Payments Data

Andrea Burkle, PA

Physician Assistant · Riverdale, GANPI 1578347720

Payments from drug & device makers

$1,621in general payments, 2019–2025

Across 67 payments — averaging $24.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$594
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$229
  • Johnson & Johnson$117
  • Sanofi$95
  • Merck$95
  • Ardelyx, Inc.$82
  • plus $408 from 10 others

What the payments were for

  • Food & beverage$1,56096%
  • Education$614%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,621 in reported general payments places this provider in the 75th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$13,749
Medicare patients
106
Services billed
121

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide48$29,673
TrulancePlecanatide16$10,989
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl112$1,650
Pantoprazole Sodium184$1,467
CholestyramineCholestyramine (With Sugar)14$1,238
Famotidine53$465
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl26$423
Omeprazole38$392
Sucralfate17$377
Dicyclomine Hcl17$269

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$594$29,67348 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$229$10,98916 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Riverdale

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →